Group 1 - The U.S. trade policy outlook remains uncertain, leading to negative market sentiment and a collective decline in major U.S. stock indices [1] - The Nasdaq Composite fell by 0.03%, the Dow Jones Industrial Average decreased by 0.31%, and the S&P 500 index dropped by 0.03% [1] - Technology stocks experienced widespread declines, with Tesla and Oracle both falling over 1% [1] Group 2 - Novo Nordisk's stock plummeted by 15% due to disappointing trial results for its new weight loss drug CagriSema, which underperformed compared to Eli Lilly's Zepbound [1]